![Dong Xu Qiu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dong Xu Qiu
Grundare på
CANSINO BIOLOGICS INC.
Förmögenhet: 78 M $ per 2026-07-31
Profil
Dong Xu Qiu is the founder of CanSino Biologics, Inc. (founded in 2009) and holds the title of Executive Vice President.
He is currently working as a Director at Suzhou GenePharma Co., Ltd. Dr. Qiu previously worked as the Head-Scientific Operations at Arius Research, Inc. from 2000 to 2002 and as the General Manager-Consulting & Research at ChinaBio LLC from 2007 to 2011.
He has a doctorate degree from Peking University (conferred in 1987), an MBA degree from the University of Western Ontario (conferred in 2000), a doctorate degree from the University of Montréal (conferred in 1993), a doctorate degree from Universität Konstanz (conferred in 1991), and an undergraduate degree from Shenyang Pharmaceutical University (conferred in 1982).
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2024-12-11 | 6 030 683 ( 9,03 % ) | 45 M $ | 2026-07-31 | |
| 2024-12-31 | 11 083 517 ( 8,35 % ) | 33 M $ | 2026-07-31 |
Aktiva positioner av Dong Xu Qiu
| Företag | Position | Start |
|---|---|---|
| CANSINO BIOLOGICS INC. | Grundare | 2009-01-13 |
Suzhou GenePharma Co., Ltd.
 Suzhou GenePharma Co., Ltd. BiotechnologyHealth Technology Offers core technologies of siRNA chemical synthesis, RNA monomer synthesis, custom and chemically-modified siRNA oligo synthesis, nucleic acid fluorescent labeling, and many nucleotide chemical modification technologies | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Dong Xu Qiu
| Företag | Position | Slut |
|---|---|---|
ChinaBio LLC
 ChinaBio LLC Financial ConglomeratesFinance Operates as an investment, consulting and media company which helps life science companies | Företagsledare/Principal | 2011-04-01 |
Arius Research, Inc.
 Arius Research, Inc. BiotechnologyHealth Technology Develops anti-cancer antibodies | Företagsledare/Principal | 2002-01-01 |
Dong Xu Qius utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
77
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Arius Research, Inc.
Arius Research, Inc. BiotechnologyHealth Technology Develops anti-cancer antibodies | Health Technology |
ChinaBio LLC
ChinaBio LLC Financial ConglomeratesFinance Operates as an investment, consulting and media company which helps life science companies | Finance |
Peking University
 Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Montréal
 University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universität Konstanz
 Universität Konstanz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenyang Pharmaceutical University
 Shenyang Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CanSino Biologics, Inc.
 CanSino Biologics, Inc. BiotechnologyHealth Technology Manufactures and commercializes vaccines | Health Technology |
Suzhou GenePharma Co., Ltd.
Suzhou GenePharma Co., Ltd. BiotechnologyHealth Technology Offers core technologies of siRNA chemical synthesis, RNA monomer synthesis, custom and chemically-modified siRNA oligo synthesis, nucleic acid fluorescent labeling, and many nucleotide chemical modification technologies | Health Technology |
